CSWYY (China Shineway Pharmaceutical Group) Net Loan


CSWYY China Shineway Pharmaceutical Group Ltd CSWYY
92 GF Score
Price $19.25
GF Value $17.03
! 2 Warning Signs
View Full Analysis

What is China Shineway Pharmaceutical Group Net Loan?

Net Loan only applies to banks and insurance companies.

CSWYY
92GF Score
China Shineway Pharmaceutical Group Ltd CSWYY
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?

Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued. The current stock price of $19.25 is trading 13% above its estimated GF Value™ of $17.03.

Key valuation signals for CSWYY:

  • Net Loan:
  • GF Value™: $17.03 vs. price of $19.25 (13% above fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Shineway Pharmaceutical Group Business Description

Other Exchanges 02877:Hong KongC1S:Germany
Address Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score

Get the complete analysis for CSWYY

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.25
Price
$17.03
GF Value